PRF Technologies shares rise 56.45% after-hours after name change reflects expansion into healthcare and AI-driven energy platforms.

PainReform surged 56.45% in after-hours trading following the announcement that shareholders approved its name change to PRF Technologies Ltd. at the January 6, 2026, annual general meeting. The rebranding reflects the company’s strategic shift from a single-asset focus to a diversified platform spanning specialty pharmaceuticals, ophthalmology treatments via LayerBio, and AI-driven renewable-energy analytics through DeepSolar. The name change underscores expansion into high-growth markets, including a patented ocular therapy for post-cataract inflammation and an AI solar analytics business entering early commercial deployment. CEO Dr. Ehud Geller emphasized the transformation from a “single program” to a multi-platform business, aligning with investor sentiment on the company’s broader market opportunities.